Extranodal NK-T-cell lymphoma medical therapy: Difference between revisions
No edit summary |
No edit summary |
||
Line 29: | Line 29: | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] |
Revision as of 20:13, 2 February 2016
Extranodal NK-T-cell lymphoma Microchapters |
Differentiating Extranodal NK-T-cell lymphoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Extranodal NK-T-cell lymphoma medical therapy On the Web |
American Roentgen Ray Society Images of Extranodal NK-T-cell lymphoma medical therapy |
Risk calculators and risk factors for Extranodal NK-T-cell lymphoma medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Overview
The predominant therapy for extranodal NK-T-cell lymphoma is radiation therapy. Adjunctive chemotherapy and stem cell transplant may be required.[1]
Medical Therapy
The predominant therapy for extranodal NK-T-cell lymphoma is radiation therapy. Adjunctive chemotherapy and stem cell transplant may be required.
Therapy | Description |
---|---|
Radiation therapy |
|
Chemotherapy |
|
Stem cell transplant |
|
References
- ↑ 1.0 1.1 Extranodal NK/T-cell lymphoma, nasal type. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/extranodal-nk-t-cell-lymphoma-nasal-type/?region=on. Accessed on February 02, 2016